Document Detail


Trends in pertussis among infants in the United States, 1980-1999.
MedLine Citation:
PMID:  14665658     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONTEXT: Reported cases of pertussis among adolescents and adults have increased since the 1980s, despite increasingly high rates of vaccination among infants and children. However, severe pertussis morbidity and mortality occur primarily among infants. OBJECTIVE: To describe the trends and characteristics of reported cases of pertussis among infants younger than 12 months in the United States from 1980 to 1999. DESIGN, SETTING, AND PARTICIPANTS: Cases of pertussis in infants younger than 12 months in the United States reported to the National Notifiable Disease Surveillance System of the Centers for Disease Control and Prevention between 1980 and 1999, and detailed case data from the Supplementary Pertussis Surveillance System. MAIN OUTCOME MEASURES: Incidence and demographic and clinical characteristics of cases. RESULTS: The incidence of reported cases of pertussis among infants increased 49% in the 1990s compared with the incidence in the 1980s (19 798 vs 12 550 cases reported; 51.1 cases vs 34.2 cases per 100 000 infant population, respectively). Increases in the incidence of cases and the number of deaths among infants during the 1990s primarily were among those aged 4 months or younger, contrasting with a stable incidence of cases among infants aged 5 months or older. The proportion of cases confirmed by bacterial culture was higher in the 1990s than in the 1980s (50% and 33%, respectively); the proportion of hospitalized cases was unchanged (67% vs 68%, respectively). Receipt of fewer doses of vaccine was associated with hospitalization, when cases were stratified by age in months. CONCLUSIONS: The incidence of reported cases of pertussis among infants increased in the 1990s compared with the 1980s. The limited age group affected, the increased rate of bacteriologic confirmation, and the unchanged severity of illness suggest that an increase in infant pertussis has occurred apart from any change in reporting. Strategies are needed to prevent the morbidity and mortality from pertussis among infants too young to be fully vaccinated, according to the current recommended schedules of vaccination in the United States.
Authors:
Masahiro Tanaka; Charles R Vitek; F Brian Pascual; Kristine M Bisgard; Jacqueline E Tate; Trudy V Murphy
Related Documents :
1766598 - New protection against haemophilus influenzae type b infections in infants and young ch...
10113878 - An investigation of maternal morbidity with identification of life-threatening 'near mi...
21692718 - Congenital cytomegalovirus - time to diagnosis, management and clinical sequelae in aus...
9464908 - Impact of disease on feedlot performance: a review.
9481078 - Digoxin-like immunoreactivity in early infantile death.
8197488 - Prevalence of hyaline membrane disease in black and white low-birth-weight infants.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  JAMA : the journal of the American Medical Association     Volume:  290     ISSN:  1538-3598     ISO Abbreviation:  JAMA     Publication Date:  2003 Dec 
Date Detail:
Created Date:  2003-12-10     Completed Date:  2003-12-15     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7501160     Medline TA:  JAMA     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2968-75     Citation Subset:  AIM; IM    
Affiliation:
Bacterial Vaccine Preventable Disease Branch, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Ga 30333, USA. mtanaka@cdc.gov
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bordetella pertussis / isolation & purification
Humans
Incidence
Infant
Pertussis Vaccine
Population Surveillance
Seasons
United States / epidemiology
Vaccination
Whooping Cough / epidemiology*,  ethnology,  prevention & control
Chemical
Reg. No./Substance:
0/Pertussis Vaccine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals.
Next Document:  Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infe...